SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019955
Filing Date
2022-05-13
Accepted
2022-05-12 18:49:27
Documents
87
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q emma-10q_20220331.htm   iXBRL 10-Q 2787546
2 EX-10.1 emma-ex101_13.htm EX-10.1 17662
3 EX-10.2 emma-ex102_14.htm EX-10.2 58598
4 EX-10.3 emma-ex103_15.htm EX-10.3 18301
5 EX-31.1 emma-ex311_6.htm EX-31.1 9931
6 EX-31.2 emma-ex312_8.htm EX-31.2 10001
7 EX-32.1 emma-ex321_7.htm EX-32.1 7798
8 GRAPHIC g1eomgg5zlyg000001.jpg GRAPHIC 1215
  Complete submission text file 0001564590-22-019955.txt   13582039

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA emma-20220331.xsd EX-101.SCH 74577
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE emma-20220331_cal.xml EX-101.CAL 71058
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE emma-20220331_def.xml EX-101.DEF 285119
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE emma-20220331_lab.xml EX-101.LAB 531854
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE emma-20220331_pre.xml EX-101.PRE 460616
81 EXTRACTED XBRL INSTANCE DOCUMENT emma-10q_20220331_htm.xml XML 3566833
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35527 | Film No.: 22919535
SIC: 2834 Pharmaceutical Preparations